For the researchers at UCLA’s Jules Stein Eye Institute who launched the first-ever study to show that human embryonic stem cells may help reverse patients’ disease, the history-making day began at 4:30 a.m. It was an early morning wake-up call, to be sure, but a necessary one to prepare for the groundbreaking work that lay ahead. On July 12, 2011, the scientists injected retinal cells derived from embryonic stem cells into the eyes of two patients suffering from progressive blindness, and the results announced Monday suggest that the treatment has changed their lives.
The international group of doctors and researchers involved in the safety trial, sponsored by Advanced Cell Technology (ACT), which produced the retinal cells, report in the journal Lancet that the patients who received the therapy are doing well, showing no signs of adverse effects from the treatment and even reporting small improvements in their vision. So far, 24 additional patients are expected to receive the same treatment.
Wednesday 25 January 2012
Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness ☀
18 notes
-
seashelllz liked this
-
jewelsbyjess liked this
-
chrysknife liked this
-
antipaladin liked this
-
buchino liked this
-
ucsdhealthsciences liked this
-
blissandzen liked this
-
mindbabies liked this
-
rainbowsawr reblogged this from technipol
-
technipol reblogged this from azspot
-
quickhits liked this
-
tumbleanddash liked this
-
billcotter liked this
-
billcotter reblogged this from azspot
-
darylelockhart reblogged this from azspot
-
azspot posted this
A GNT creation ©2007–2011
